Insider buying on Sep 8, 2025

On Sep 8, 2025, 49 insiders at 40 companies filed 69 purchases reported on Form 4, worth $52.5M in all, with a median purchase of $40.4K. The largest was Ra Capital Management, L.p., Director of Mineralys Therapeutics, Inc. (MLYS), who reported buying 1,176,470 shares worth $30.0M. Officers accounted for 26 purchases, directors who are not officers for 28, and 10% owners with no board or officer role for 12. Chief executives and chief financial officers filed 16 purchases: Cordova Ashley, Chief Executive Officer of NovoCure Ltd (NVCR); Dixon Robert E, CEO/President of MacKenzie Realty Capital, Inc. (MKZR); Manheimer Mark, President, CEO and Secretary, Director of NETSTREIT Corp. (NTST) among others. 13 companies showed cluster buying, two or more insiders buying within 7 days, among them MKZR (6 insiders), SHEN (6 insiders), HKHC (3 insiders), MLYS (2 insiders). For 9 insiders of 49, this was the first purchase of that company's stock on our record. A Form 4 is due within two business days of the trade, so most of these purchases were made earlier in the week. Code P also covers shares bought privately from the company, so one large figure can be a negotiated placement rather than buying on the exchange.